A research team has developed a novel multidimensional sampling theory to overcome the limitations of flat optics. The study not only identifies the constraints of conventional sampling theories in ...

Develop research skills in biotechnology and scientific knowledge applicable to a range of careers, including working as a consultant, in business development, as a research and development manager, ...

The development of the biotechnology and medical industry has boosted the ... there is a relative lack of research on consumer behavior. Therefore, this study investigates the relationship pattern of ...

Soon after starting a new biotechnology company, David Li realized he needed to rethink his strategy. Li had been conducting the competitive research biotech entrepreneurs typically undertake before ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...

The Tata IISc Medical School will be a centre of excellence that seeks to catalyse a unique model of clinical research and medical education in India, by bringing basic science and engineering to bear ...

Each organization is collaborating with nearby research universities to build on biotech research and expansion in their regions. CvilleBioHub, a regional, industry-led organization, received $4.3 ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology ... manufacturing to early research. Last week, U.S. lawmakers ...

At a time when pharma interest in AI capabilities is surging, it is no surprise that a biotech focused on using “emerging AI tools” in drug discovery and development would have such strong backing.

The Japanese pharma giant is teaming up with independent research institute BioMed X to form a new research group to work on targeting solid tumors with multispecific biologics, including antibodies.

There’s also uncertainty about when biotech demand will stabilize. Investors debate whether $14 or $15 per share was the right target for the quarter. The initial guidance for next year will ...